［13］ Lincoff AM, Furst JG, Ellis SG, et al. Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury model［J］. Am Coil Cardiol, 1997,29（4）:808-816.
［14］ Schellhammer F, Berlis A, Bloss H, et al. Polylacticacid coating for endovascular stents. Preliminary results in canine experimental arteriovenous fistulae［J］. Invest Radiol, 1997,32（3）:180-186.
［15］ Strecker EP, Gabelmann A, Boos I, et al. Effect on intimal hyperplasia of dexamethasone released from coated metal stents compared with noncoated stents in canine femoral arteries［J］. Cardiovasc Intervent Radiol, 1998,21（6）1:487-496.
［16］Alt E, Haehnel I, Beilharz C, et al. Inhibition of neointima formation after experimental coronary artery stenting: a new biodegradable stent coating releasing hirudin and the prostacyclin analogue iloprost［J］. Circulation, 2000,101（12）:1453-1458.
［17］ Alt E, Seliger C. Antithrombotic stent coatings: hirudin/iloprost combination［J］. Semin Interv Cardiol, 1998,3（34）:177-183.
［18］ Cater AJ, Kopia G, Llanos G, et a1. Stent based sirolimus delivery reduces neointimal proliferation in a porcine coronary model of restenosis［J］. Am Coil Cardiol, 2000,35（7）:13.
［19］ Sousa JE, Costa MA, Abizaid AC, et al. Sustained suppression of neointimal proliferation by sirolimuseluting stents: oneyear angiographic and intravascular ultrasound followup［J］. Circulation, 2001,104（17）:2007-2011.
［20］ Susawa T, Shiraki K, Shimizu Y. Biodegradable intracoronary stents in adult dogs［J］. JACC, 1993,21（Suppl 2）:483A.
［21］ Tamai H, Igaki K, Kyo E, et al. Initial and 6month results of biodegradable polyllactic acid coronary stents in humans［J］. Circulation, 2000,102（4）:399-404.
［22］ Uurto I, Juuti H, Parkkinen J, et al. Biodegradable selfexpanding polyL/Dlactic acid vascular stent: a pilot study in canine and porcine iliac arteries［J］. Endovasc Ther, 2004,11（6）:712-718.
［23］ Vogt F, Stein A, Rettemeier G, et al. Longterm assessment of a novel biodegradable paclitaxeleluting coronary polylactide stent［J］. Eur Heart J, 2004,25（15）:1330-1340.
［24］ Uurto I, Mikkonen J, Parkkinen J, et al. Drugeluting biodegradable polyD/Llactic acid vascular stents: an experimental pilot study［J］. Endovasc Ther, 2005,12（3）:371-379.
［25］ Waksman R. Biodegradable stents: they do their job and disappear［J］. J Invasive Cardiol, 2006,18(2):70-74.
